Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.04 (1.50%)
Bid:
2.705
Ask:
2.73
Spread: 0.025 (0.924%)
Market Cap: $8.91b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB 1st Quarter Separate Financial Results

24 May 2021 07:00

RNS Number : 5016Z
Commercial Intnl Bank (Egypt) SAE
24 May 2021
Β 

Β 

Β 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31, 2021

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5016Z_1-2021-5-21.pdf

Β 

Β 

Condensed Separate Interim Balance Sheet as at March 31,2021

Β 

Β 

Notes

Mar. 31, 2021

Β 

Dec. 31, 2020

Β 

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Assets

Β 

Β 

Β 

Β 

Β 

Cash and balances at the central bank

7

21,580,813

Β 

33,572,597

Β 

Due from banks

8

97,069,002

Β 

86,997,034

Β 

Loans and advances to banks, net

10

781,084

Β 

776,980

Β 

Loans and advances to customers, net

11

120,303,607

Β 

118,854,880

Β 

Derivative financial instruments

Β 

290,438

Β 

248,759

Β 

Investments

Β 

Β 

Β 

Β 

Β 

- Financial Assets at Fair Value through P&L

12

341,120

Β 

359,959

Β 

- Financial Assets at Fair Value through OCI

12

167,580,005

Β 

147,646,432

Β 

- Amortized cost

12

24,677,774

Β 

25,020,917

Β 

- Investments in associates and subsidiaries

13

1,032,708

Β 

874,348

Β 

Other assets

Β 

9,424,894

Β 

9,095,212

Β 

Deferred tax assets (Liabilities)

Β 

431,534

Β 

437,772

Β 

Property and equipment

14

2,466,612

Β 

2,259,940

Β 

Total assets

Β 

445,979,591

Β 

426,144,830

Β 

Liabilities and equity

Β 

Β 

Β 

Β 

Β 

Liabilities

Β 

Β 

Β 

Β 

Β 

Due to banks

15

2,511,475

Β 

8,815,561

Β 

Due to customers

16

365,162,571

Β 

340,086,524

Β 

Derivative financial instruments

Β 

306,569

Β 

331,073

Β 

Current tax liabilities

Β 

830,536

Β 

859,582

Β 

Other liabilities

Β 

6,763,064

Β 

5,679,266

Β 

Other loans

Β 

7,732,536

Β 

7,746,946

Β 

Provisions

17

3,270,735

Β 

3,221,252

Β 

Total liabilities

Β 

386,577,486

Β 

366,740,204

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Issued and paid up capital

Β 

14,776,813

Β 

14,776,813

Β 

Reserves

Β 

40,231,425

Β 

33,085,554

Β 

Reserve for employee stock ownership plan (ESOP)

Β 

1,227,099

Β 

1,064,648

Β 

Retained earnings *

Β 

3,166,768

Β 

10,477,611

Β 

Total equity and net profit for the period / year

Β 

59,402,105

Β 

59,404,626

Β 

Total liabilities and equity

Β 

445,979,591

Β 

426,144,830

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

The accompanying notes are an integral part of these financial statements.

Β 

Β 

Β 

Β 

Β 

(Review report attached)

Β 

Β 

Β 

Β 

*

Including net profit for the current period

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Hussein Abaza

Sherif Samy

Β 

CEO & Board member

Chairman

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Income Statement for the period ended March 31, 2021

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Notes

Β 

Mar. 31, 2021

Mar. 31, 2020

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

EGP Thousands

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Interest and similar income

Β 

Β 

10,120,581

10,687,101

Β 

Β 

Β 

Β 

Β 

Interest and similar expense

Β 

Β 

(4,444,196)

(4,491,834)

Β 

Β 

Β 

Β 

Β 

Net interest income

Β 

Β 

5,676,385

6,195,267

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Fee and commission income

Β 

Β 

844,128

805,413

Β 

Β 

Β 

Β 

Β 

Fee and commission expense

Β 

Β 

(333,561)

(305,561)

Β 

Β 

Β 

Β 

Β 

Net fee and commission income

Β 

Β 

510,567

499,852

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Dividend income

Β 

Β 

91

-

Β 

Β 

Β 

Β 

Β 

Net trading income

5

Β 

112,718

(5,425)

Β 

Β 

Β 

Β 

Β 

Profits (Losses) on financial investments

12

Β 

493,655

470,150

Β 

Β 

Β 

Β 

Β 

Administrative expenses

Β 

Β 

(1,472,944)

(1,523,538)

Β 

Β 

Β 

Β 

Β 

Other operating (expenses) income

Β 

Β 

(526,604)

(747,740)

Β 

Β 

Β 

Β 

Β 

Impairment release (charges) for credit losses

Β 

Β 

(702,082)

(1,240,110)

Β 

Β 

Β 

Β 

Β 

Profit before income tax

Β 

Β 

4,091,786

3,648,456

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Income tax expense

Β 

Β 

(1,209,247)

(1,332,487)

Β 

Β 

Β 

Β 

Β 

Deferred tax assets (Liabilities)

Β 

Β 

(6,239)

75,241

Β 

Β 

Β 

Β 

Β 

Net profit for the period

Β 

Β 

2,876,300

2,391,210

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Earning per share

6

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Basic

Β 

Β 

1.72

1.43

Β 

Β 

Β 

Β 

Β 

Diluted

Β 

Β 

1.71

1.42

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

HusseinΒ Abaza

Β 

Sherif Samy

Β 

Β 

Β 

Β 

Β 

Β 

CEOΒ &Β BoardΒ member

Β 

Chairman

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim statement of Comprehensive Income for the period ended March 31, 2021

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Mar. 31, 2021

Β 

Mar. 31, 2020

Β 

Β 

Β 

Β 

Β 

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net profit for the period

Β 

Β 

Β 

2,876,300

Β 

2,391,210

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Change in fair value of debt instruments measured at fair value through other comprehensive income

Transferred from reserve on disposal of financial assets at fair value through OCI

Effect of ECL in fair value of debt instruments measured at fair value through OCI

Total comprehensive income for the period

Β 

Β 

Β 

Β 

(1,674,309)

(104,406)

(14,644)

1,082,941

Β 

Β 

(4,865,970)

-

(47,321)

(2,522,081)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Cash flows for the period ended March 31, 2021

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Notes

Mar. 31, 2021

Β 

Mar. 31, 2020

Β 

Β 

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from operating activities

Β 

Β 

Β 

Β 

Β 

Profit before income tax

Β 

4,091,786

Β 

3,648,456

Β 

Adjustments to reconcile net profit to net cash provided by operating activities

Β 

Β 

Β 

Β 

Β 

Fixed assets depreciation

14

194,609

Β 

160,538

Β 

Impairment charge for credit losses (Loans and advances to customers and banks)

Β 

720,756

Β 

1,272,649

Β 

Other provisions charges

17

114,144

Β 

439,410

Β 

Impairment charge for credit losses (due from banks)

Β 

(4,030)

Β 

14,782

Β 

Impairment charge for credit losses (financial investments)

Β 

(14,644)

Β 

(47,321)

Β 

Impairment charge for other assets

Β 

12,676

Β 

13,707

Β 

Exchange revaluation differences for financial assets at fair value through OCI

Β 

23,042

Β 

287,889

Β 

Impairment charge financial assets at fair value through OCI

Β 

(72,957)

Β 

69,863

Β 

Exchange differences in financial investments in subsidiary

Β 

-

Β 

719

Β 

Utilization of other provisions

17

(43,518)

Β 

(726)

Β 

Other provisions no longer used

17

(5,872)

Β 

(38,630)

Β 

Exchange differences of other provisions

17

(15,271)

Β 

(22,219)

Β 

(Profits) losses from selling property, plant and equipment

Β 

(1,250)

Β 

(94)

Β 

(Profits) losses from selling financial investments

12

(420,698)

Β 

(554,113)

Β 

Shares based payments

Β 

162,451

Β 

145,069

Β 

Released (Impairment) charges of investments in associates and subsidiaries

Β 

-

Β 

14,100

Β 

Operating profits before changes in operating assets and liabilities

Β 

4,741,224

Β 

5,404,079

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net decrease (increase) in assets and liabilities

Β 

Β 

Β 

Β 

Β 

Due from banks

Β 

(12,278,859)

Β 

211,025

Β 

Financial assets at fair value through P&L

12

18,839

Β 

104,116

Β 

Derivative financial instruments

Β 

(66,183)

Β 

35,892

Β 

Loans and advances to banks and customers

10 - 11

(2,173,587)

Β 

2,428,551

Β 

Other assets

Β 

(284,984)

Β 

857,769

Β 

Due to banks

15

(6,304,086)

Β 

(1,372,684)

Β 

Due to customers

16

25,076,047

Β 

5,513,465

Β 

Income tax obligations paid

Β 

(29,046)

Β 

(4,639,364)

Β 

Other liabilities

Β 

(236,449)

Β 

(722,423)

Β 

Net cash used in (generated from) operating activities

Β 

8,462,916

Β 

7,820,426

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from investing activities

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Proceeds (payments) for investment in associates.

Β 

(158,360)

Β 

-

Β 

Payment for purchases of property, plant, equipment and branchesΒ constructions

Β 

(347,656)

Β 

(319,089)

Β 

Proceeds from selling property, plant and equipment

Β 

1,250

Β 

94

Β 

Proceeds from redemption of financial assets at amortized cost

Β 

346,898

Β 

45,639,889

Β 

Payment for purchases of financial assets at amortized cost

Β 

(3,844)

Β 

(44,945,839)

Β 

Payment for purchases of financial assets at fair value through OCI

Β 

(55,216,492)

Β 

(62,050,349)

Β 

Proceeds from selling financial assets at fair value through OCI

Β 

34,497,956

Β 

54,866,521

Β 

Net cash generated from (used in) investing activities

Β 

(20,880,248)

Β 

(6,808,773)

Β 

Β 

Condensed Separate Interim Cash flows for the period ended March 31, 2021 (Cont.)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Mar. 31, 2021

Β 

Mar. 31, 2020

Β 

Β 

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Β 

Β 

Received (Repaid) in long term loans

Β 

(14,410)

Β 

(91,576)

Β 

Dividend paid

Β 

(1,360,652)

Β 

(3,370,464)

Β 

Net cash generated from (used in) financing activities

Β 

(1,375,062)

Β 

(3,462,040)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net increase (decrease) in cash and cash equivalent during the period

Β 

(13,792,394)

Β 

(2,450,387)

Β 

Beginning balance of cash and cash equivalent

Β 

75,965,247

Β 

22,895,017

Β 

Cash and cash equivalent at the end of the period

Β 

62,172,853

Β 

20,444,630

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalent comprise:

Β 

Β 

Β 

Β 

Β 

Cash and balances at the central bank

Β 

21,580,813

Β 

27,169,495

Β 

Due from banks

Β 

97,088,303

Β 

26,640,005

Β 

Treasury bills and other governmental notes

Β 

52,339,135

Β 

29,091,960

Β 

Obligatory reserve balance with CBE

Β 

(15,671,568)

Β 

(22,186,285)

Β 

Due from banks with maturities more than three months

Β 

(40,498,431)

Β 

(10,415,104)

Β 

Treasury bills with maturity more than three months

Β 

(52,665,399)

Β 

(29,855,441)

Β 

Total cash and cash equivalent

Β 

62,172,853

Β 

20,444,630

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2020

Β 

Mar. 31, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

EGP Thousands

Β 

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

Β 

Transferred to reserves

-

590,106

7,840,286

-

1,440

-

-

(8,431,832)

-

-

Β 

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

Β 

Net profit for the period

-

-

-

-

-

-

-

2,391,210

-

2,391,210

Β 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(4,865,970)

-

-

-

(4,865,970)

Β 

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

Β 

ECL for impairment of debt instruments investments

-

-

-

-

-

(47,321)

-

-

-

(47,321)

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

145,069

145,069

Β 

Ending balance

14,690,821

2,778,135

24,314,715

1,549,445

14,906

(801,510)

6,423

2,391,210

1,108,221

46,052,366

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2021

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Mar. 31, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

EGP Thousands

Β 

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Β 

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Β 

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Β 

Net profit for the period

-

-

-

-

-

-

-

2,876,300

-

2,876,300

Β 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(104,406)

-

104,406

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Β 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(1,674,309)

-

-

-

(1,674,309)

Β 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Β 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(14,644)

-

-

-

(14,644)

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

162,451

162,451

Β 

Β 

Ending balance

14,776,813

3,293,074

33,186,137

1,549,445

16,000

2,177,628

9,141

3,166,768

1,227,099

59,402,105

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
QRFUAONRABUVUAR
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.